Skip to main content
TipRanks
Go Ultimate75% OFF

Thomas Andrew Davis Insider Profile

4 Followers

Thomas Andrew Davis, Executive VP & CMO at Celldex, holds 68.33K shares in Genocea Biosciences (Ticker: GNCAQ), holds 1.01K shares in Celldex (Ticker: CLDX), holds 5.00K shares in GenVec Inc (Ticker: GNVC). Most recently, Thomas Andrew Davis Sold ― shares of Genocea Biosciences on Apr 05, 2022 for an estimated value of $1.36K.

Thomas Andrew Davis's Trading History

GNCAQ
Genocea Biosciences
Apr 05, 2022―Informative Sell1.36K―
CLDX
Celldex
Sep 17, 2010Executive VP & CMOInformative Buy9.44K$28.90K
GNVC
GenVec Inc
―――$35.97K

You May Also Like

Thomas Andrew Davis insider profile FAQ

What stocks does Thomas Andrew Davis hold?
Thomas Andrew Davis holds: CLDX, GNCAQ, GNVC stocks.
What was Thomas Andrew Davis’s latest transaction?
Thomas Andrew Davis’s latest transaction was an Informative Sell of $1.36K.
What is Thomas Andrew Davis's role in Celldex?
Thomas Andrew Davis's role in Celldex is Executive VP & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.